Suchergebnisse - "Hsu, Ann"

PubPharm (14)

1

Conversion to carbidopa and levodopa extended-release (IPX066) followed by its extended use in patients previously taking controlled-release carbidopa-levodopa for advanced Parkinson's disease

enthalten in: Journal of the neurological sciences | 2017

von Tetrud, J. | Nausieda, P. | Kreitzman, D. | +11

2

Clinical Pharmacokinetics of IPX066 : Evaluation of Dose Proportionality and Effect of Food in Healthy Volunteers

enthalten in: Clinical neuropharmacology | 2016

von Yao, H. | Hsu, A. | Gupta, S. | +1

3

Comparison of the pharmacokinetics of an oral extended-release capsule formulation of carbidopa-levodopa (IPX066) with immediate-release carbidopa-levodopa (Sinemet(®)), sustained-release carbidopa-levodopa (Sinemet(®) CR), and carbidopa-levodopa-entacapone (Stalevo(®))

enthalten in: Journal of clinical pharmacology | 2015

von Hsu, A. | Yao, H. | Gupta, S. | +1

4

Long-Term Treatment with Extended-Release Carbidopa-Levodopa (IPX066) in Early and Advanced Parkinson's Disease : A 9-Month Open-Label Extension Trial

enthalten in: CNS drugs | 2015

von Waters, C. | Nausieda, P. | Dzyak, L. | +8

5

Long-Term Treatment with Extended-Release Carbidopa–Levodopa (IPX066) in Early and Advanced Parkinson’s Disease: A 9-Month Open-Label Extension Trial

enthalten in: CNS drugs | 2015

von Waters, C. | Nausieda, P. | Dzyak, L. | +8

6

Long-Term Treatment with Extended-Release Carbidopa–Levodopa (IPX066) in Early and Advanced Parkinson’s Disease: A 9-Month Open-Label Extension Trial

enthalten in: CNS drugs | 2015

von Waters, C. | Nausieda, P. | Dzyak, L. | +8

7

Conversion to IPX066 from Standard Levodopa Formulations in Advanced Parkinson's Disease : Experience in Clinical Trials

enthalten in: Journal of Parkinson's disease | 2015

von Nausieda, P. | Hsu, A. | Elmer, L. | +8

8

Comparison of IPX066 with carbidopa-levodopa plus entacapone in advanced PD patients

enthalten in: Parkinsonism & related disorders | 2014

von Stocchi, F. | Hsu, A. | Khanna, S. | +7

9

Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease

enthalten in: Parkinsonism & related disorders | 2014

von Pahwa, R. | Lyons, K. | Hauser, R. | +64

10

Population pharmacodynamics of IPX066 : an oral extended-release capsule formulation of carbidopa-levodopa, and immediate-release carbidopa-levodopa in patients with advanced Parkinson's disease

enthalten in: Journal of clinical pharmacology | 2013

von Mao, Z. | Hsu, A. | Gupta, S. | +1